Navigation Links
ARIUS announces fourth quarter and year-end fiscal 2007 financial results
Date:1/29/2008

om the Takeda collaboration.

Interest income decreased to $679,457 for the year ended November 30, 2007, compared to $726,308 for the same period in fiscal 2006. For the three-month period ended November 30, 2007, the Company's interest income decreased to $142,329 compared to $329,342 for the same period in fiscal 2006. The decrease in interest income is the result of lower average cash and investment balances.

Research and development costs amounted to $8,606,344 for the year ended November 30, 2007, compared to $5,688,029 for the same period in fiscal 2006. For the three-month period ended November 30, 2007, the Company's research and development costs amounted to $2,144,353 compared to $2,512,366 for the same period in fiscal 2006. For the year, this increase is primarily the result of increased product development activity, including process development and scale-up, as the Company prepares several of its programs for the clinic as well as an increase in staffing levels and stock option remuneration expense. For the three month period, the decrease in research and development costs is primarily the result of decreased stock option remuneration expense and a decrease in legal expense for patents, offset by an increase in staffing levels.

General and administrative expenses increased to $3,257,430 for the year ended November 30, 2007, compared to $2,833,802 for the same period in fiscal 2006. For the three-month period ended November 30, 2007, the Company's general and administrative expenses decreased to $691,910 compared to $806,589 for the same period in fiscal 2006. The increase for the year is the result of increased head count, stock option remuneration expense, and severance costs, partially offset by decreased consulting and legal costs. The decrease for the three month period is the result of a decrease in stock option remuneration expense, professional fees and salaries, partially offset by an increase in consulting and directors fe
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
2. ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
3. ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody
4. ARIUS to present at BioNorth Biotechnology and Life Sciences Conference
5. Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
6. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
7. ARIUS to present at Chinese Global Financial Forum
8. Arius highlighted at AACR-NCI-EORTC 2007 International Cancer Conference
9. ARIUS Announces Third Quarter Fiscal 2007 Financial Results
10. Arius Features Preclinical Data on Antibody Candidates at Two Conferences
11. China Bionanometer Industries Corporation Announces Record Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Shimadzu Scientific Instruments today announces ... spectrophotometer. Offering wavelength scanning from 190 to 1,100 ... applications in a variety of industries, including environmental, ... UV-1280 enables intuitive operation, while the enhanced validation, ...
(Date:1/22/2015)... laboratory information management systems market is a rapidly growing ... due to factors such as rising pressure to comply ... and increasing government support for adoption of HCIT solutions ... the market focus on technological advancements to further the ...
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently ... Supplements Pre-Conference seminar on probiotics in San Diego, CA. ... education conference for health care professionals. This year’s pre-conference seminar ... probiotics in health. Dr. Leyer spoke about the emerging topics ...
(Date:1/22/2015)... SAN DIEGO , Jan. 22, 2015   ... company, and Sequenom, Inc. (NASDAQ: SQNM ... a development agreement for next generation noninvasive prenatal ... Cypher,s genome interpretation technology, called Mantis™, to advance ...
Breaking Biology Technology:Shimadzu’s New Monitored Single-Beam UV-Vis Spectrophotometer Offers Comprehensive Measurement Options in a Compact Body 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 4Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4
... - GeneNews Limited (TSX: GEN),a company focused ... the early detection of diseases and personalized ... collecting patient samples,for clinical validation studies of ... June 2006, GeneNews presented training set results ...
... /PRNewswire-FirstCall/ - Helix BioPharma Corp.,(TSX, FSE: "HBP") today ... by way of private placement, of a total ... gross proceeds totaling CDN$16,867,200.,Proceeds from the placement will ... Company,s research and development initiatives., The Company ...
... and Product Development Company to Establish Presence in ... UK/European Market from the Midlands, ... announced that Nebraska based GeneSeek has chosen the British,Midlands as ... be setting up their new base of operations in BioCity,Nottingham, ...
Cached Biology Technology:GeneNews initiates patient sample accrual for validation studies of colon cancer blood test 2GeneNews initiates patient sample accrual for validation studies of colon cancer blood test 3Helix BioPharma announces $16.9 million private placement of common shares 2GeneSeek Selects the British Midlands as Base for New UK/European Operations 2GeneSeek Selects the British Midlands as Base for New UK/European Operations 3
(Date:12/17/2014)... YORK , Dec. 15, 2014  HITLAB SM ... (GCP) audit to confirm its adherence to current U.S. ... HITLAB to conduct regulated smart device and smart phone ... and research quality. "HITLAB is determined to ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" report ... Facial recognition is a technology used ... the overall facial feature of a person such as ...
(Date:12/11/2014)... , Dec. 10, 2014  Data Sciences International ... has released a new series of digital telemetry ... toxicology researchers. M series, part of the PhysioTel™ ... the best possible physiologic data when incorporating functional ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3New telemetry implants expected to change how large animal toxicology studies are conducted 2
... team of scientists from the United States and the United ... organic matter in soils that they say could be used ... researchers, proposed instrumentation could operate on any Mars lander or ... NASA,s Mars Science Laboratory scheduled for launch in 2009 ...
... Genetic studies on small organisms such as worms and ... new microfluidic device developed by engineers at the Georgia ... position, image, determine the phenotype of and sort small ... commonly used for biological studies. "Classical genetic approaches ...
... decade, the drug called tPA has proven its worth as ... of stroke. But its promise is blemished by two facts: ... brain-saving power fades fast after the third hour of a ... Nature Medicine reveals why tPA has these limitations. It ...
Cached Biology News:Laser fluorescence could find life on Mars 2Laser fluorescence could find life on Mars 3Laser fluorescence could find life on Mars 4Automated microfluidic device reduces time to screen small organisms for genetic studies 2Automated microfluidic device reduces time to screen small organisms for genetic studies 3Stroke study reveals key target for improving treatment and suggests that Gleevec may help 2Stroke study reveals key target for improving treatment and suggests that Gleevec may help 3Stroke study reveals key target for improving treatment and suggests that Gleevec may help 4
Immulon 2HB, Flat Bottom, 50/Bx; high binding irradiated surface to provide increased binding affinity for hydrophilic proteins and complexes....
96 Well Plate Sterile, RE bottom; consistent medium binding affinity for hydrophobic complexes and proteins....
96 Well Plate EB, RE bottom; high binding irradiated surface to provide increased binding affinity for hydrophilic proteins and complexes. Guaranteed coefficient of variation (CVs)....
... Tabletop orbital shakers combine high durability and ... patented triple-counterbalanced heavy-duty mechanism prevents vibration, allowing ... out-of-balance loads. Every other part, from the ... the thick machined aluminum platform is designed ...
Biology Products: